DONALD GARMON: Open Payments
NPI 1962608109 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 8 payments from 4 companies in 2025. Trend: 2023 $232 · 2024 $135 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Ardelyx, Inc. | 1 | $28 |
| PENTAX of America, Inc. | 1 | $23 |
Products named: VOWST, IBSRELA, GATTEX, INSPIRA, ENTYVIO.
Industry payments across NY — which companies pay providers there.
